Epidemiology & antibiograms of Vibro cholerae isolates from a tertiary care hospital in Chandigarh, north India

Indian Journal of Medical Research

Volumn 129, Issue 5, 2009, Pages 613-617

  Chander, Jagdish ^a   Kaistha, Neelam ^a   Gupta, Varsha ^a   Mehta, Manjula ^a   Singla, Nidhi ^a   Deep, Antariksh ^a   Sarkar, B L ^b  

^a GOVERNMENT MEDICAL COLLEGE AND HOSPITAL   (India)

^b NATIONAL INSTITUTE OF CHOLERA AND ENTERIC DISEASES   (India)

Author keywords

Cholera; Drug resistance; Epidemiology; Ogawa; Phage type; Vibrio cholerae

Indexed keywords

AMOXICILLIN; CEFOTAXIME; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; FURAZOLIDONE; GENTAMICIN; TETRACYCLINE; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIOPHAGE T4; BACTERIOPHAGE TYPING; BACTERIUM ISOLATION; CHILD; CHOLERA; DISK DIFFUSION; ENVIRONMENTAL SANITATION; ESCHERICHIA COLI; FEMALE; HUMAN; INDIA; INFANT; INFECTION CONTROL; INFECTION RATE; MALE; NONHUMAN; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SCHOOL CHILD; SEASONAL VARIATION; SUBURBAN AREA; TERTIARY HEALTH CARE; TREND STUDY; VIBRIO CHOLERAE; AGE; DRUG EFFECT; DRUG RESISTANCE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; SEROTYPING; SEX DIFFERENCE;

AGE FACTORS; AMOXICILLIN; ANTI-BACTERIAL AGENTS; CEFOTAXIME; CHOLERA; CIPROFLOXACIN; DRUG RESISTANCE; FEMALE; FURAZOLIDONE; GENTAMICINS; HUMANS; INDIA; MALE; MICROBIAL SENSITIVITY TESTS; RETROSPECTIVE STUDIES; SEROTYPING; SEX FACTORS; VIBRIO CHOLERAE O1;

EID: 70349143483     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Kaper JB, Morris JG Jr, Levine MM. Cholera. Clin Microbiol Rev 1995; 8: 48-86.
2. Sack DA, Sack RB, Nair GB, Siddique AK. Cholera. Lancet 2004; 363: 223-33.
3. [No authors listed] Cholera, 2006. Wkly Epidemiol Rec 2007; 82: 273-84.
4. Lipp EK, Huq A, Colwell RR. Effects of global climate on infectious disease: the Cholera model. Clin Microbiol Rev 2002; 15: 757-70.
5. Nair GB. How much more research is required to prevent cholera? Indian J Med Res 2007; 125: 612-4.
6. Sharma NC, Mandal PK, Dhillon R, Jain M. Changing profile of Vibrio cholerae O1, O139 in Delhi & its periphery (2003-2005). Indian J Med Res 2007; 125: 633-40.
7. Tilak VW, Bhalwar R, Ratti JS. Epidemiological study of an outbreak of cholera in Delhi cantonment. Indian J Public Health 1997; 41: 61-7.
8. Gupta A, Jain S, Mahawal BS. Outbreak of cholera in arid zone of Bikaner. Indian J Med Res 1999; 110: 126-7.
9. Gupta DN, Sarkar BL, Bhattacharya MK, Sengupta PG, Bhattacharya SK. An El Tor cholera outbreak in Maldah district, West Bengal. J Commun Dis 1999; 31: 49-52.
10. Sur D, Sarkar BL, Manna B, Deen J, Datta S, Niyogi SK, et al. Epidemiological, microbiological & electron microscopic study of a cholera outbreak in a Kolkata slum community. Indian J Med Res 2006; 123: 31-6.
11. Sabeena F. Thirivikramji G, Radhakutty G, Indu P, Singh DV. In vitro susceptibility of Vibrio cholerae O1 biotype El Tor strains associated with an outbreak of cholera in Kerala, southern India. J Antimicrob Chemother 2001; 47: 361-2.
12. Thakur JS, Swami HM, Dutt R, Mehta M, Gupta V. Epidemiological investigation of cholera outbreak in a periurban slum colony in Chandigarh. Indian J Med Sci 2001; 55: 429-33.
13. Taneja N, Kaur J, Sharma K, Singh M, Kalra JK, Sharma NM, et al. A recent outbreak of cholera due to Vibrio cholerae O1 Ogawa in & around Chandigarh, north India. Indian J Med Res 2003; 117: 243-6.
14. Kaistha N, Mehta M, Gautam V, Gupta V. Outbreak of cholera in & around Chandigarh during two successive years (2002, 2003). Indian J Med Res 2005; 122: 404-7.
15. World Health Organization, Geneva. Manual for laboratory investigations of acute enteric infections 1987; WHO document CDD/ 83.3/Rev.1.113.
16. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 15th Informational Supplement: Wayne, Pa., USA: Clinical and Laboratory Standards Institute; 2005; M100- S15.
17. Basu S, Mukerjee S. Bacteriophage typing of Vibrio el tor. Experientia 1968; 24: 299-300.
18. Chattopadhyay DJ, Sarkar BL, Ansari MQ, Chakrabarti BK, Roy MK, Ghosh AN, et al. New phage typing scheme for Vibrio cholerae O1 biotype El Tor isolates. J Clin Microbiol 1993; 31: 1579-85.
19. Slathia P, Bansal MP. Incidence of Vibrio cholerae in different age groups and sex in Aurangabad Province isolated during January 1994 to December 1994. Indian J Med Sci 1999; 53: 349-51.
20. Niyogi SK, Mondal S, Sarkar BL, Garg S, Banerjee D, Dey GN. Outbreak of cholera due to Vibrio cholerae O1 in Orissa state. Indian J Med Res 1994; 100: 217-8.
21. Niyogi SK, De SP. Prevalence of biotypes, serotypes & phagetypes of Vibrio cholerae O-1 in India (1975-1985). Indian J Med Res 1987; 85: 1-4.
22. Sarkar BL, Roy MK, Chakrabarti AK, Niyogi SK. Distribution of phage type of Vibrio cholerae O1 biotype El Tor in Indian scenario (1991-98). Indian J Med Res 1999; 109: 204-7.
23. Bhattacharya SK. An evaluation of current cholera treatment. Expert Opin Pharmacother 2003; 4: 141-6.
24. Tauxe RV, Blake PA. Epidemic cholera in Latin America. JAMA 1992: 267: 1388-90.
25. Sack DA, Lyke C, McLaughlin C, Suwanvanichkij V. Antimicrobial resistance in shigellosis, cholera and campylobacteriosis. Geneva: World Health Organization; 2001.
26. Garg P, Chakraborty S, Basu I, Datta S, Rajendran K, Bhattacharya T, et al. Expanding multiple antibiotic resistance among clinical isolates of Vibrio cholerae isolated from 1992-7 in Calcutta, India. Epidemiol Infect 2000; 124: 393-9.
27. Mukhopadhyay AK, Basu I, Bhattacharya SK, Bhattacharya MK, Nair GB. Emergence of fluoroquinolone resistance in isolates of Vibrio cholerae isolated from hospitalized patients with acute diarrhea in Calcutta, India. Antimicrob Agents Chemother 1998; 42: 206-7.